Block of voltage-gated calcium channels stimulates dopamine efflux in rat mesocorticolimbic system

Neuropharmacology

Volumn 56, Issue 6-7, 2009, Pages 984-993

  Belardetti, Francesco ^a   Ahn, Soyon ^a   So, Kitty ^b   Snutch, Terrance P ^b,c   Phillips, Anthony G ^b  

^a Neuromed Pharmaceuticals   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dopamine; Drug dependency; GABA; Mesocorticolimbic system; Microdialysis; NP078585; Voltage gated calcium channel

Indexed keywords

1 [6,6 BIS(4 FLUOROPHENYL)HEXYL] 4 (3,4,5 TRIMETHOXYBENZYL)PIPERAZINE; BICUCULLINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; DOPAMINE; HALOPERIDOL; NP 078585; OMEGA CONOTOXIN GVIA; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DEPENDENCE; DRUG DOSE COMPARISON; GABAERGIC SYSTEM; LIMBIC SYSTEM; MALE; MESOCORTICOLIMBIC SYSTEM; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CALCIUM CHANNELS, T-TYPE; DENDRITES; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; ION CHANNEL GATING; MALE; NUCLEUS ACCUMBENS; OMEGA-CONOTOXIN GVIA; PIPERAZINES; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 67349189985     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.02.001     Document Type: Article

References (56)

1. B receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Neuropharmacology 46 (2004) 1082-1088
2. Bergquist F., Jonason J., Pileblad E., and Nissbrandt H. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J. Neurochem. 70 (1998) 1532-1540
3. Björklund A., and Lindvall O. Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res. 83 (1975) 531-537
4. 2+ channels. Ann. Rev. Cell. Dev. Biol. 16 (2000) 521-555
5. 2+ channels contrasted with strong regulation of axonal dopamine release. J. Neurochem. 96 (2006) 645-655
6. Cobb W.S., and Abercrombie E.D. Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol. J. Neurosci. 22 (2002) 1407-1413
7. B receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 65 (2002) 209-220
8. B receptor agonists on the mesolimbic dopamine system. Nat. Neurosci. 7 (2004) 153-159
9. Darracq L., Drouin C., Blanc G., Glowinski J., and Tassin J.P. Stimulation of metabotropic but not ionotropic glutamatergic receptors in the nucleus accumbens is required for the d-amphetamine-induced release of functional dopamine. Neuroscience 103 (2001) 395-403
10. De Melo Reis R.A., Ventura A.L., Schitine C.S., de Mello M.C., and de Mello F.G. Müller glia as an active compartment modulating nervous activity in the vertebrate retina: neurotransmitters and trophic factors. Neurochem Res. 33 (2008) 1466-1474
11. Dobrev D., Milde A.S., Andreas K., and Ravens U. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum. Br. J. Pharmacol. 127 (1999) 576-582
12. Dunlap K., Luebke J.I., and Turner T.J. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci. 18 (1995) 89-98
13. Elverfors A., Jonason J., Jonason G., and Nissbrandt H. Effects of drugs interfering with sodium channels and calcium channels on the release of endogenous dopamine from superfused substantia nigra slices. Synapse 26 (1997) 359-369
14. Falkenburger B.H., Barstow K.L., and Mintz I.M. Dendrodendritic inhibition through reversal of dopamine transport. Science 293 (2001) 2465-2470
15. Fallon J.H., and Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180 (1978) 545-580
16. Fibiger H.C., and Phillips A.G. Mesocorticolimbic dopamine systems and reward. Ann. N.Y. Acad. Sci. 537 (1988) 206-215
17. Geffen L.B., Jessell T.M., Cuello A.C., and Iversen L.L. Release of dopamine from dendrites in rat substantia nigra. Nature 260 (1976) 258-260
18. Grace A.A., and Onn S.P. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J. Neurosci. 9 (1989) 3463-3481
19. 3H-dopamine from primary cultures of mesencephalic neurons. Neuropharmacology 28 (1989) 1275-1278
20. 2+-dependent burst firing in GABAergic neurons of rat thalamic reticular nucleus. J. Neurosci. 12 (1992) 3804-3817
21. Inazu M., Takeda H., and Matsumiya T. The role of glial monoamine transporters in the central nervous system. Nihon Shinkei Seishin Yakurigaku Zasshi 23 (2003) 171-178
22. Johnson S.W., and North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12 (1992) 483-488
23. (v)3.3 channels. Br. J. Pharmacol. 144 (2005) 59-70
24. Kahlig K.M., Binda F., Khoshbouei H., Blakely R.D., McMahon D.G., Javitch J.A., and Galli A. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 3495-3500
25. Kandel E.R. Disorders of thought and volition: schizophrenia. In: Kandel E.R. (Ed). Principles of Neural Science (2000), McGraw-Hill, New York 1188-1208
26. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13 (1992) 177-184
27. Kupfermann I., Kandel E.R., and Iversen S. Motivational and addictive states. In: Kandel E.R. (Ed). Principles of Neural Science (2000), McGraw-Hill, New York 998-1018
28. Kuroki T., Meltzer H.Y., and Ichikawa J. 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res. 972 (2003) 216-221
29. Newton P.M., Orr C.J., Wallace M.J., Kim C., Shin H.S., and Messing R.O. Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice. J. Neurosci. 24 (2004) 9862-9869
30. Newton P.M., Zeng L., Wang V., Connolly J., Wallace M., Kim C., Shin H.-S., Belardetti F., Snutch T.P., and Messing R. A blocker of N- and T-type voltage-gated calcium channels attenuates ethanol-induced intoxication, place preference, self-administration, and reinstatement. J. Neurosci. 28 (2008) 11712-11719
31. Olivera B.M., Miljanich G.P., Ramachandran J., and Adams M.E. Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-agatoxins. Annu. Rev. Biochem. 63 (1994) 823-867
32. Ohlsen R.I., and Pilowsky L.S. The place of partial agonism in psychiatry: recent developments. J. Psychopharmacol. 19 (2005) 408-413
33. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, London
34. Peleg-Raibstein D., and Feldon J. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release. Neuropharmacology 51 (2006) 947-957
35. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol. Rev. 83 (2003) 117-161
36. Pezze M.A., and Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog. Neurobiol. 74 (2004) 301-320
37. Phillips P.E., and Stamford J.A. Differential recruitment of N-, P- and Q-type voltage-operated calcium channels in striatal dopamine release evoked by 'regular' and 'burst' firing. Brain Res. 884 (2000) 139-146
38. Poncer J.-C., McKinney R.A., Gahwiler B.H., and Thompson S.M. Either N- or P-type calcium channels mediate GABA release at distinct hippocampal inhibitory synapses. Neuron 18 (1997) 463-472
39. Rahman S., and McBride W.J. Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area. J. Neurochem. 80 (2002) 646-654
40. 2+ channel. EMBO J. 20 (2001) 2349-2356
41. Santi C.M., Cayabyab F.S., Sutton K.G., McRory J.E., Mezeyova J., Hamming K.S., Parker D., Stea A., and Snutch T.P. Differential inhibition of T-type calcium channels by neuroleptics. J. Neurosci. 22 (2002) 396-403
42. Schroeder C.I., Doering C.J., Zamponi G.W., and Lewis R.J. N-type calcium channel blockers: novel therapeutics for the treatment of pain. Med Chem. 2 (2006) 535-543
43. Schultz W. Behavioral dopamine signals. Trends Neurosci. 30 (2007) 203-210
44. Snutch T.P. Targeting chronic and neuropathic pain: the N-type calcium channel comes of age. NeuroRx 2 (2005) 662-670
45. Snutch T.P., Feng Z.P., Doering C., Cayabyab F., Janke D., Parker D.B., Belardetti F., Morimoto B., Vanderah T., Zamponi G.W., and Porreca F. A new class of N-type calcium channel blocker efficacious in animal models of chronic pain. Soc. Neurosci. (2001) 465.1
46. Snutch T.P., Sutton K.G., and Zamponi G.W. Voltage-dependent calcium channels-beyond dihydropyridine antagonists. Curr. Opin. Pharmacol. 1 (2001) 11-16
47. Snutch, T., Feng, Z., Doering, C., Cayabyab, F., Janke, D., Parker, D., Belardetti, F., Morimoto, B., Venderah, B., Zamponi, G., Porreca, F., 2003. Novel N-type calcium channel blockers efficacious in animal models of chronic pain. In: 226th ACS National Meeting, Paper 6.
48. Snutch T.P., Peloquin J., Mathews E., and McRory J. Molecular properties of voltage-gated calcium channels. In: Zamponi G. (Ed). Voltage-gated Calcium Channels (2005), Landes Bioscience, New York 61-94
49. Tamminga C.A., and Carlsson A. Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis. Curr. Drug Targets CNS Neurol. Disord. 1 (2002) 141-147
50. Vacca G., Ahn S., So K., Snutch T.P., Phillips A.G., and Belardetti F. Block of N-type calcium channels stimulates the release of dopamine from rat mesolimbic neurons. Soc. Neurosci. (2005) Abs 265.2
51. Westerink B.H., Kwint H.F., and deVries J.B. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci. 16 (1996) 2605-2611
52. Wise R.A. Forebrain substrates of reward and motivation. J. Comp. Neurol. 493 (2005) 115-121
53. Wood P.B. Mesolimbic dopaminergic mechanisms and pain control. Pain 120 (2006) 230-234
54. Wolfart J., and Roeper J. Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J. Neurosci. 22 (2002) 3404-3413
55. You Z.B., Chen Y.Q., and Wise R.A. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience 107 (2001) 629-639
56. Zamponi G.W. Cytoplasmic determinants of piperidine blocking affinity for N-type calcium channels. J. Membr. Biol. 167 (1999) 183-192